Major Pharmaceuticals
Major Pharmaceuticals appears in FDA public data with 19 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0708-2026, Class II) was initiated on July 13, 2026.
Summary
- Total Recalls
- 19
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0708-2026 | Class II | Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 10 Tablets (10 x 1) unit dose blisters per car | July 13, 2026 |
| D-0702-2026 | Class II | Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per c | July 13, 2026 |
| D-0706-2026 | Class II | Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 100 Tablets (10 x 10 unit dose blisters) per | July 13, 2026 |
| D-0705-2026 | Class II | Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 100 Tablets (10 x 10 unit dose blisters) per | July 13, 2026 |
| D-0700-2026 | Class II | Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Tablets (10 x 10 unit dose blisters) per c | July 13, 2026 |
| D-0701-2026 | Class II | Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Tablets (10 x 10 unit dose blisters) per c | July 13, 2026 |
| D-0703-2026 | Class II | Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per c | July 13, 2026 |
| D-0709-2026 | Class II | Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters per car | July 13, 2026 |
| D-0707-2026 | Class II | Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 10 Tablets (10 x 1) unit dose blisters per car | July 13, 2026 |
| D-0704-2026 | Class II | Levothyroxine Sodium Tablets, USP, 112 mcg (0.0112 mg), 100 Tablets (10 x 10 unit dose blisters) per | July 13, 2026 |
| D-0711-2026 | Class II | Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per c | July 13, 2026 |
| D-0710-2026 | Class II | Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 10 Tablets (10 x 1) unit dose blisters per c | July 13, 2026 |
| D-1583-2019 | Class II | DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS, USP Tablets, 250 mg, 100 count-unit dose carton, RX only | April 24, 2019 |
| D-1466-2019 | Class II | Losartan Potassium Tablets, USP. 50 mg. NDC# 0904-6390-61. Rx only. 100 count Unit Dose Cartons. Man | January 10, 2019 |
| D-1026-2018 | Class II | Doxycycline Hyclate Tablets, USP, 100 mg, Rx Only, 30 tablets, 3 x 10 unit dose Cartons, Mfd. by: We | July 30, 2018 |
| D-0967-2018 | Class II | Unit Dose Valsartan Tablets, USP. 160 mg. Rx only.,Distributed by: Major Pharmaceuticals, Livonia, | July 18, 2018 |
| D-0966-2018 | Class II | Unit Dose Valsartan Tablets, USP, 80 mg. Rx only, Distributed by: Major Pharmaceuticals, Livonia, M | July 18, 2018 |
| D-0979-2018 | Class III | Enalapril Maleate Tablets, USP, 2.5 mg, 100 Tablets (10 x 10) Unit Dose per carton, Rx only, Manufac | June 26, 2018 |
| D-0980-2018 | Class III | Enalapril Maleate Tablets, USP, 5 mg, 100 Tablets (10 x 10) Unit Dose per carton, Rx only, Manufactu | June 26, 2018 |